A blog dedicated to the study of complex relationships in pharmacology; with a medicolegal perspective. “Journalism is printing what someone else does not want printed: everything else is public relations.” ― George Orwell | CC-0
“The past several years have born exciting developments for those critical of the current psychiatric paradigm. We have witnessed outright criticism of the DSM by prominent psychiatrists (i.e., Thomas Insel, Allen Frances) while others have admitted that no “biological markers” exist for any DSM-defined disorder (Kupfer, 2013). Amazingly, however, the suggested response to these problems is to continue pursuing the search for the biological underpinnings of so-called “mental illness” through an almost evangelical hyper-focus on brain research. In other words, the leaders of mental health are essentially saying “We have spent 100 years diligently categorizing all the ways that people may suffer emotionally, searched for genetic, brain, and chemical abnormalities, and developed hundreds of drugs to target these ‘diseases’, yet we are no better off than we were 100 years ago. So, we have decided to double-down and spend more money and dedicate more intense efforts at doing the exact same thing in the future”.
This response is problematic for so many reasons. The International Society for Ethical Psychology & Psychiatry (an organization whose mission is to educate the public about the “de-humanizing and coercive aspects of many forms of mental health treatment, and the alternative humane ways of helping people who struggle with very difficult life issues”) has issued a publicly available paper scientifically challenging these efforts and suggesting ways in which our finite resources may be more effectively directed. The paper is available for download here.” [ . . . ]